SG11202105172PA - Biomarkers for cardiovascular events - Google Patents
Biomarkers for cardiovascular eventsInfo
- Publication number
- SG11202105172PA SG11202105172PA SG11202105172PA SG11202105172PA SG11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA
- Authority
- SG
- Singapore
- Prior art keywords
- biomarkers
- cardiovascular events
- cardiovascular
- events
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/04—Phospholipids, i.e. phosphoglycerides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/08—Sphingolipids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862776272P | 2018-12-06 | 2018-12-06 | |
| PCT/EP2019/084008 WO2020115288A1 (fr) | 2018-12-06 | 2019-12-06 | Marqueurs biologiques pour événements cardiovasculaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202105172PA true SG11202105172PA (en) | 2021-06-29 |
Family
ID=68808396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202105172PA SG11202105172PA (en) | 2018-12-06 | 2019-12-06 | Biomarkers for cardiovascular events |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220003791A1 (fr) |
| EP (1) | EP3891509A1 (fr) |
| JP (1) | JP2022508322A (fr) |
| KR (1) | KR20210100679A (fr) |
| CN (1) | CN113396334A (fr) |
| CA (1) | CA3122035A1 (fr) |
| SG (1) | SG11202105172PA (fr) |
| WO (1) | WO2020115288A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11143659B2 (en) | 2015-01-27 | 2021-10-12 | Arterez, Inc. | Biomarkers of vascular disease |
| EP4043884A1 (fr) | 2021-02-10 | 2022-08-17 | Eberhard-Karls-Universität Tübingen | Acyles gras et phospholipides à chaîne moyenne en tant que biomarqueurs de maladies cardiovasculaires |
| US11735303B2 (en) * | 2021-06-22 | 2023-08-22 | David Haase | Apparatus and method for determining a composition of a replacement therapy treatment |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5739898B2 (ja) * | 2009-11-17 | 2015-06-24 | ベイラー リサーチ インスティテュートＢａｙｌｏｒ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ | 心疾患マーカーとしての尿中トリアオシルセラミド（ｇｂ３） |
| EP2385374B2 (fr) | 2010-05-05 | 2018-02-28 | Zora Biosciences OY | Biomarqueurs lipidomiques pour l'athérosclérose et les maladies cardiovasculaires |
| EP2583107A2 (fr) | 2010-06-20 | 2013-04-24 | Zora Biosciences OY | Biomarqueurs lipidomique pour l'identification de haut risque patients coronariens |
| EP2592422A1 (fr) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Biomarqueurs lipidomiques pour la prédiction des résultats cardiovasculaires chez des patients atteints de coronaropathie prenant un traitement par statine |
| EP2592423A1 (fr) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Biomarqueurs lipidomiques pour la prédiction des résultats cardiovasculaires chez des patients atteints de coronaropathie ne prenant pas un traitement par statine |
| WO2014135696A1 (fr) * | 2013-03-08 | 2014-09-12 | Zora Biosciences Oy | Marqueurs cvd issus d'une lipoprotéine non à densité élevée |
| KR101565889B1 (ko) * | 2014-04-23 | 2015-11-06 | 연세대학교 산학협력단 | 혈장 대사체를 이용한 혈관경직도 예측 또는 진단 방법 |
| US9347960B2 (en) * | 2014-06-16 | 2016-05-24 | Zora Biosciences, Oy | Ceramides and their use in diagnosing CVD |
| CA3013316A1 (fr) * | 2016-02-04 | 2017-08-10 | Metanomics Gmbh | Moyens et procedes pour distinguer l'insuffisance cardiaque de la maladie pulmonaire chez un sujet |
-
2019
- 2019-12-06 CN CN201980091282.1A patent/CN113396334A/zh active Pending
- 2019-12-06 SG SG11202105172PA patent/SG11202105172PA/en unknown
- 2019-12-06 JP JP2021531869A patent/JP2022508322A/ja active Pending
- 2019-12-06 US US17/295,139 patent/US20220003791A1/en active Pending
- 2019-12-06 WO PCT/EP2019/084008 patent/WO2020115288A1/fr unknown
- 2019-12-06 KR KR1020217021198A patent/KR20210100679A/ko unknown
- 2019-12-06 CA CA3122035A patent/CA3122035A1/fr active Pending
- 2019-12-06 EP EP19816678.7A patent/EP3891509A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020115288A1 (fr) | 2020-06-11 |
| US20220003791A1 (en) | 2022-01-06 |
| JP2022508322A (ja) | 2022-01-19 |
| CA3122035A1 (fr) | 2020-06-11 |
| KR20210100679A (ko) | 2021-08-17 |
| EP3891509A1 (fr) | 2021-10-13 |
| CN113396334A (zh) | 2021-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201902077D0 (en) | Biomarkers | |
| SG11202105172PA (en) | Biomarkers for cardiovascular events | |
| GB201704267D0 (en) | Novel biomarker | |
| GB201703058D0 (en) | Biomarkers | |
| GB2596456B (en) | Immunoassay for mitragynine | |
| GB201908780D0 (en) | Melanoma biomarkers | |
| GB201911947D0 (en) | Miscarriage biomarkers | |
| GB201804648D0 (en) | Combination biomarker | |
| GB201703123D0 (en) | Biomarkers | |
| GB201900677D0 (en) | Biomarkers | |
| GB201909228D0 (en) | Screen for inhibitors | |
| GB201814807D0 (en) | Dementia Biomarkers | |
| GB201811093D0 (en) | Biomarker | |
| GB201706064D0 (en) | Biomarkers for glucocorticoid action | |
| SG11202110589PA (en) | Biomarkers for selinexor | |
| EP3807614C0 (fr) | Microtome | |
| PT3894133T (pt) | Um eletrofuso | |
| PT3894132T (pt) | Um eletrofuso | |
| GB201915228D0 (en) | Biomarkers | |
| GB201902070D0 (en) | Biomarkers | |
| GB201914183D0 (en) | Biomarker | |
| GB201913846D0 (en) | Biomarker | |
| GB201913612D0 (en) | Biomarker | |
| GB201912154D0 (en) | Biomarker | |
| GB201911078D0 (en) | Biomarker |